Rankings
▼
Calendar
COLL Q2 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$24M
Net Income
-$25M
EPS (Diluted)
$-1.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$120M
Total Liabilities
$21M
Stockholders' Equity
$99M
Cash & Equivalents
$111M
← FY 2016
All Quarters
Q3 2016 →
